TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,105,467 | +184.5% | 136,100 | +158.3% | 0.02% | +128.6% |
| Q2 2022 | $740,000 | +118.9% | 52,700 | +123.3% | 0.01% | +133.3% |
| Q1 2022 | $338,000 | -25.2% | 23,600 | -28.9% | 0.00% | -25.0% |
| Q4 2021 | $452,000 | -84.5% | 33,200 | -80.9% | 0.00% | -87.1% |
| Q2 2021 | $2,921,000 | +215.4% | 173,500 | +242.2% | 0.03% | +181.8% |
| Q1 2021 | $926,000 | -86.3% | 50,700 | -86.6% | 0.01% | -87.9% |
| Q2 2020 | $6,768,000 | +597.0% | 377,528 | +587.7% | 0.09% | +167.6% |
| Q2 2019 | $971,000 | -13.1% | 54,900 | 0.0% | 0.03% | -12.8% |
| Q1 2019 | $1,118,000 | – | 54,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |